Advertisement

Transition to Survivorship

  • Pamela Goetz
  • Jennifer R. Klemp
Chapter

Abstract

Cancer leads patients on a trajectory, including diagnosis, treatment, survivorship, and care through the balance of ones’ life. Each phase makes distinct demands on the patient, caregivers, healthcare providers, and complicated healthcare delivery systems. This chapter addresses survivorship care and the need for ongoing health maintenance from the perspective of the patient and their healthcare providers, including the vital role of navigation. The chapter will provide a broad description of the crosscutting issues surrounding cancer survivorship and will close with an example of survivorship care in practice.

References

  1. 1.
    National Coalition for Cancer Survivorship. Self-advocacy: a cancer survivors handbook. www.canceradvocacy.org/cancer-advocacy/what-is-advocacy. 2009. Accessed 28 Jun 2017.
  2. 2.
    Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985;313:270–3.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
  4. 4.
    Institute of Medicine (IOM). Cancer care for the whole patient: meeting psychosocial health needs. Washington, DC: The National Academies Press; 2007.  https://doi.org/10.17226/11993.CrossRefGoogle Scholar
  5. 5.
    NCCN Clinical Practice Guidelines in Oncology: Distress management. V.2.2017. www.nccn.org. Accessed 18 Oct 2017.
  6. 6.
    Forsythe LP, Kent EE, Weaver KE, et al. Receipt of psychosocial care among cancer survivors in the United States. J Clin Oncol. 2013;31:1961–9.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
  8. 8.
    Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975–2014. Bethesda, MD: National Cancer Institute. April 2017. https://seer.cancer.gov/csr/1975_2014.
  9. 9.
    Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006.  https://doi.org/10.17226/11468.CrossRefGoogle Scholar
  10. 10.
  11. 11.
    American College of Surgeons Commission on Cancer. www.facs.org/quality-programs/cancer/coc/standards. Accessed 25 Jul 2017.
  12. 12.
    American Society of Clinical Oncology Institute for Quality. Quality oncology practice initiative (QOPI®). www.instituteforquality.org/quality-oncology-practice-initiative-qopi. Accessed 25 Jul 2017.
  13. 13.
    National Comprehensive Cancer Network (NCCN). www.nccn.org/. Accessed 25 Jul 2017.
  14. 14.
    American Society for Clinical Oncology (ASCO) Survivorship Guide (for patients). www.cancer.net/survivorship. Accessed 25 Jul 2017.
  15. 15.
    National Institutes of Health, U.S. National Library of Medicine. Irinotecan hydrochloride and cetuximab with or without ramucirumab in treating patients with advanced colorectal cancer with progressive disease after treatment with bevacizumab-containing chemotherapy. https://clinicaltrials.gov/ct2/show/NCT01079780. Accessed 25 Jul 2017.

Patient Resources

  1. Association of Community Cancer Centers. Survivorship care. www.accc-cancer.org/home/learn/Patient-Centered-Care/survivorship-care.
  2. American Society for Clinical Oncology. Survivorship (for patients). www.cancer.net/survivorship.
  3. American Institute of Cancer Research (AICR). www.aicr.org.
  4. CancerCare. www.cancercare.org.
  5. Cancer Support Community. www.cancersupportcommunity.org.
  6. National Center for Complementary and Integrative Health. https://nccih.nih.gov.
  7. National Coalition for Cancer Survivorship. www.canceradvocacy.org.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Center for Patient and Family ServicesSibley Memorial Hospital, Johns Hopkins MedicineWashington, DCUSA
  2. 2.Division of Clinical Oncology Director, Cancer Survivorship Cancer Risk and Genetic CounselingThe University of Kansas Cancer CenterWestwoodUSA

Personalised recommendations